CADDA

CADDA is a strategic collaboration of three academic partner institutions (University of Kent, The University of Manchester and UCL), backed by four years funding support from Research England. During the development of the CADDA programme we sought and gained advice from a range of diagnostics organisations, these included trade bodies, NHS Trusts, large businesses and SMEs for both human and animal health.

Our partners are helping us with their time and resources, offering advice, governance and support to CADDA, they are vital to our organisation.

If you are interested in learning more about becoming a CADDA partner, please email cadda@kent.ac.uk

The University of Kent provides inter-disciplinary knowledge for CADDA. Led by Professor Mark Smales in the School of Natural Sciences, Co-Director Professor Kathy Kotiadis bring knowledge of business process. Within the University a diversity of experience in human and veterinary science,  advanced optical systems for imaging and sensing, clinical care systems, data science and cyber security, a School of Pharmacy and Kent and Medway Medical School. External links to NHS, Health Trusts, private sector, charities and  Knowledge Transfer Networks with facilities for extended development at Discovery Park (Sandwich), Kent Science Park (Sittingbourne) and Maidstone Medical Campus. The University is co-lead of the EPSRC funded future blood testing diagnostic network.

Led by Professor Alan Dickson, the Director of the Centre of Excellence in Biopharmaceuticals (COEBP) at the University of Manchester. The University  of Manchester will support CADDA in a number of ways including through The Manchester Institute of Biotechnology (MIB), with a focus on developing next-generation diagnostic tools to increase screening and testing capacity and accuracy. A strategic partnership between Manchester University NHS Foundation Trust (MFT), Siemens Healthineers and UoM on development of diagnostics for cancers and other conditions. The Diagnostics and Technology Accelerator (DiTA) supports generation of digital products, medical technologies and in vitro diagnostics, working to co-develop new diagnostics with industry, NHS, clinicians, patients, regulators and the public. The University provides regional focus, managed by a co-lead, Dr Joanne Flannelly.

Led by Professor Jolene Skordis, from the UCL Centre for Global Health. UCL Global brings a range of activities to CADDA. These include economic analysis of potential health intervention(s) based around diagnostics and how these might be repurposed for LMICs, and thus where need and impact are identified. Economic evaluation of potential clinical trials. Direct links into wider Institute for Global Health and links to agencies, NGOs and NHS that may wish to adopt or consider SME developed diagnostics. UCL offers support through the TRO Translational Research Group (TRG) establishing and sustaining a large portfolio of funded UCL translational projects.